Global Emerging Blood Typing, Grouping and NAT Screening Tests Market Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Abbott, Immucor, Roche - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/prw5q4/20162020) has announced the addition of the "2016-2020 Emerging Blood Typing, Grouping and NAT Screening Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers" report to their offering.

This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

Competitive Assessments:

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • CellMark Forensics/LabCorp
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Immucor
  • Ortho-Clinical Diagnostic
  • Proteome Sciences
  • Quest
  • Quidel
  • Roche
  • Siemens
  • Tecan
  • Thermo Fisher/Life Technologies

For more information visit http://www.researchandmarkets.com/research/prw5q4/20162020

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Coagulation and Hemostasis Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Coagulation and Hemostasis Testing